• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines Polyhalopyridines

Market Research and Analysis of 2,3,5-Trichloro-6-Hydrazinylpyridine in Chemical Biomedical Field

The compound 2,3,5-trichloro-6-hydrazinylpyridine (CAS No. 55933-94-3) has garnered significant attention in the chemical biomedical field due to its unique properties and potential applications. This analysis aims to provide a comprehensive overview of the latest research findings, market demands, and industry trends surrounding this compound.

Recent studies have highlighted the role of 2,3,5-trichloro-6-hydrazinylpyridine in various biomedical applications, including drug development and therapeutic interventions. Its chemical structure makes it a valuable intermediate in the synthesis of complex molecules with bioactive properties. Researchers have explored its potential as an anti-inflammatory agent and its ability to modulate cellular pathways involved in disease progression.

Market analysis indicates a growing demand for this compound due to its versatility and increasing use in preclinical studies. Key players in the pharmaceutical industry are actively seeking suppliers capable of providing high-purity samples to meet the rising demand for research and development activities. Additionally, regulatory advancements and the need for innovative therapeutic solutions are driving the market growth of this compound.

The global supply chain for 2,3,5-trichloro-6-hydrazinylpyridine is concentrated among a few specialized manufacturers who adhere to stringent quality control measures. Procurement strategies often involve long-term partnerships to ensure consistent supply and meet the rigorous standards required by the biomedical industry.

In conclusion, 2,3,5-trichloro-6-hydrazinylpyridine (CAS No. 55933-94-3) remains a critical component in the chemical biomedical landscape. Its continued relevance is underscored by ongoing research into its therapeutic potentials and its pivotal role in drug discovery processes. As the industry evolves, maintaining a robust supply chain and fostering innovation will be essential to capitalize on the opportunities presented by this compound.

• 138705-60-9(3,6-Dichloro-2-hydrazinylpyridine)
• 104408-23-3(3,5-Dichloro-2-hydrazinylpyridine)
• 51501-52-1(tetrachloropyridin-2-amine)
• 1378670-79-1(3,5,6-Trichloropyridin-2-amine)
• 30332-26-4(2,3,4,5-tetrachloro-6-hydrazinylpyridine)
• 22841-92-5(3-Chloro-2-hydrazinopyridine)
• 1361399-75-8(2,3-dichloro-6-hydrazinylpyridine)
• 837365-03-4(2,4-dichloro-6-hydrazinylpyridine)
• 1034303-16-6(3-Chloro-2-hydrazinylpyridine hydrochloride)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)